您的位置: 首页 > 农业专利 > 详情页

Targeting HER2 and HER3 with bispecific antibodies in cancerous cells
专利权人:
The University of Texas System;Board of Regents
发明人:
E. Sally Ward,Raimund Ober,Jeffrey Kang,Jayakumar Poovassery
申请号:
US15023648
公开号:
US10519247B2
申请日:
2014.10.31
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The disclosure provides monoclonal bispecific antibodies targeting HER2 and HER3. The disclosure also provides monospecific tetravalent HER3 antigen binding antibodies. Still further provided by the disclosure are methods of treating a cancer in a subject, comprising administering to the subject a therapeutically effective amount of an antibody provided by the disclosure.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充